3.2 Preterm Labor, Tocolysis, Corticosteroids & Neuroprotection
Key Takeaways
- Preterm labor is regular contractions with cervical change before 37 weeks; a negative fetal fibronectin result can be reassuring in the tested population but does not replace cervical and clinical assessment.
- Tocolysis is short-term, usually to gain time for corticosteroids or transfer. Nifedipine, indomethacin at earlier gestations, or selected beta-agonist use may be considered; contraindications determine eligibility.
- Magnesium sulfate is used for fetal neuroprotection when early preterm birth is anticipated, not as an effective treatment to prolong pregnancy.
- Antenatal corticosteroids are recommended in the standard preterm window and may be considered at the margins when delivery risk and planned neonatal resuscitation meet current guidance.
- Do not delay indicated birth for infection, major hemorrhage, severe maternal disease, or nonreassuring fetal status merely to finish steroids or tocolysis.
3.2 Preterm Labor & High-Risk Intrapartum Conditions
Preterm labor (PTL) remains a leading cause of neonatal morbidity and mortality worldwide. Inpatient obstetric nurses play a vital role in identifying PTL risk factors, interpreting diagnostic screening tools, administering targeted tocolytic therapies, ensuring antenatal corticosteroid delivery, and executing intrapartum Group B Streptococcus (GBS) antibiotic prophylaxis.
Preterm Labor: Definition & Diagnostic Tools
Preterm labor is defined as progressive cervical effacement and/or dilation associated with regular uterine contractions occurring between 20+0 and 36+6 weeks gestation.
Diagnostic Biomarkers & Clinical Screening
- Transvaginal Ultrasound (TVUS) Cervical Length: Normal cervical length at 24 weeks is 35–40 mm. A cervical length <25 mm prior to 24 weeks indicates a high risk for preterm birth.
- Fetal Fibronectin (fFN): An extracellular matrix glycoprotein acting as biological "glue" between the fetal membranes and maternal decidua. Collected via sterile swab from the posterior vaginal fornix between 22+0 and 34+6 weeks.
- Negative fFN Result: Has a high negative predictive value for near-term birth in the validated symptomatic population. Predictive value depends on baseline risk; use it with cervical length and clinical assessment when deciding about admission, transfer, corticosteroids, or tocolysis.
- Positive fFN Result: Indicates disrupted choriodecidual interface, but low positive predictive value (~15-25%). Requires clinical correlation.
- Specimen Validity: Collect before a digital cervical examination and follow assay instructions. Recent intercourse, cervical manipulation, bleeding, or ruptured membranes can make a result inapplicable or falsely positive; these factors affect interpretation rather than functioning as identical clinical contraindications.
Pharmacologic Management & Tocolytic Therapies
The primary clinical objective of tocolytic therapy is short-term delay of delivery (up to 48 hours). Tocolytics do not prevent preterm birth permanently, but they buy crucial time to: (1) administer antenatal corticosteroids for fetal lung maturation, and (2) transport the pregnant patient to a tertiary center with a Neonatal Intensive Care Unit (NICU).
Comparison of Common Tocolytic Agents
| Medication | Role | Major cautions |
|---|---|---|
| Nifedipine | Common short-term calcium-channel-blocking tocolytic | Hypotension, dizziness; assess hemodynamics and concurrent medications |
| Indomethacin | Prostaglandin inhibitor used selectively at earlier gestations | Gestational-age and duration limits because of fetal ductal and fluid effects |
| Terbutaline | Short-term beta-agonist rescue in selected acute settings | Maternal tachycardia, dysrhythmia, pulmonary edema, hyperglycemia; not prolonged maintenance |
| Magnesium sulfate | Fetal neuroprotection, not effective pregnancy-prolonging tocolysis | Respiratory depression and neuromuscular toxicity; monitor per protocol |
Tocolysis is generally inappropriate when continued pregnancy is more dangerous, including significant hemorrhage, intraamniotic infection, severe maternal instability, fetal demise or lethal anomaly, or fetal status requiring birth.
Magnesium Sulfate Safety
When magnesium is administered, independently verify the concentration, pump, line, and indication. Assess respiratory rate and oxygenation, consciousness, deep-tendon reflexes, urine output, renal function, and concurrent medications at the ordered interval. Routine serum levels are not a universal neuroprotection target; obtain them for renal impairment, suspected toxicity, or protocol indication. If reflexes disappear, respirations decline, consciousness worsens, or oliguria raises concern, stop the infusion, call for help, support ventilation, and prepare calcium gluconate per the emergency order.
Antenatal Corticosteroids & Magnesium Neuroprotection
A single corticosteroid course is standard when preterm birth is likely within 7 days from 24+0 through 33+6 weeks, including with ruptured membranes when appropriate. It may be considered beginning at 22 weeks when neonatal resuscitation is planned after counseling, and for selected patients 34+0 through 36+6 weeks at high risk of birth within 7 days who have not received a prior course.
- Betamethasone: 12 mg IM, two doses 24 hours apart.
- Dexamethasone: 6 mg IM, four doses 12 hours apart.
Do not delay medically indicated birth to complete the course. Monitor glucose closely in diabetes.
For anticipated early preterm birth, administer magnesium sulfate for fetal neuroprotection according to the facility gestational-age and dosing protocol. Monitor respiratory rate, oxygenation, consciousness, deep-tendon reflexes, urine output, and infusion rate. Keep calcium gluconate available. Concomitant nifedipine is not an automatic prohibition but requires careful monitoring.
Bedside Evaluation & Birth Preparation
Contractions alone do not establish preterm labor. At triage, characterize frequency and pain, assess cervical change over time, determine membrane status, and look for bleeding, infection, abruption, urinary disease, dehydration, or another trigger. Obtain fetal status and presentation and avoid repeated digital examinations when membranes may be ruptured. Hydration and bed rest are not universal treatments; prolonged activity restriction can add thromboembolic and deconditioning risk.
When preterm birth may occur, notify neonatal and anesthesia teams early, prepare thermoregulation and resuscitation equipment, confirm whether maternal transfer is safer before birth, and support shared counseling about neonatal goals. Explain that steroids, magnesium neuroprotection, antibiotics, and tocolysis have different indications—one does not substitute for another.
Infection Prevention Link
Preterm labor or membrane rupture often triggers GBS prophylaxis when culture status or circumstances indicate it. Use the complete susceptibility-based regimen and timing principles in Section 2.5. Begin indicated antibiotics promptly, and do not delay necessary delivery solely to achieve four hours of exposure.
A patient at 28 weeks gestation receiving a continuous intravenous infusion of magnesium sulfate for fetal neuroprotection before anticipated early preterm birth exhibits a respiratory rate of 10 breaths/min, absent patellar deep tendon reflexes, and a urine output of 18 mL over the past hour. What is the nurse's immediate action?
A pregnant patient at 30 weeks gestation is admitted in active preterm labor. The provider orders indomethacin for short-term tocolysis. Why is indomethacin therapy restricted to gestations under 32 weeks and limited to a maximum duration of 48 hours?
A patient at 30 weeks is expected to give birth within several hours. What is the primary purpose of administering magnesium sulfate in this setting?